BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10875466)

  • 1. Risk factors for presentation with bleeding in patients with Helicobacter pylori-related peptic ulcer diseases.
    Hsu PI; Lai KH; Tseng HH; Lin CK; Lo GH; Cheng JS; Chan HH; Chen GC; Jou HS; Peng NJ; Ger LP; Chen W; Hsu PN
    J Clin Gastroenterol; 2000 Jun; 30(4):386-91. PubMed ID: 10875466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: a multicenter case-control study.
    Tzourmakliotis D; Economou M; Manolakopoulos S; Bethanis S; Bergele C; Lakoumentas J; Sclavos P; Milionis H; Margeli A; Vogiatzakis E; Avgerinos A
    Scand J Gastroenterol; 2004 Dec; 39(12):1180-5. PubMed ID: 15742993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
    Stack WA; Atherton JC; Hawkey GM; Logan RF; Hawkey CJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):497-506. PubMed ID: 11876703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding peptic ulcers and presence of Helicobacter pylori by various tests: a case-control study.
    Castillo-Rojas G; Ballesteros MA; Ponce de León S; Morales-Espinosa R; Cravioto A; López-Vidal Y
    Eur J Gastroenterol Hepatol; 2002 Oct; 14(10):1113-8. PubMed ID: 12362102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Gonzalez L; de Pedro A; Valbuena M; Prieto B; Llorca I; Briz R; Khorrami S; Garcia-Gravalos R; Pajares JM
    Scand J Gastroenterol; 2001 Jul; 36(7):717-24. PubMed ID: 11444470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users.
    Santolaria S; Lanas A; Benito R; Pérez-Aisa Mf; Montoro M; Sainz R
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1511-8. PubMed ID: 10571609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.
    Papatheodoridis GV; Papadelli D; Cholongitas E; Vassilopoulos D; Mentis A; Hadziyannis SJ
    Am J Med; 2004 May; 116(9):601-5. PubMed ID: 15093756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
    al-Assi MT; Genta RM; Karttunen TJ; Graham DY
    Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic detection of CagA positive Helicobacter pylori strains predicts the presence of peptic ulcer in young dyspeptic patients.
    Rokkas T; Liatsos C; Karameris A; Petridou E; Papatheodorou G; Kalafatis E
    Gastrointest Endosc; 1999 Oct; 50(4):511-5. PubMed ID: 10502172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
    Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.
    Aalykke C; Lauritsen JM; Hallas J; Reinholdt S; Krogfelt K; Lauritsen K
    Gastroenterology; 1999 Jun; 116(6):1305-9. PubMed ID: 10348813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
    Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
    J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
    Nagata N; Niikura R; Sekine K; Sakurai T; Shimbo T; Kishida Y; Tanaka S; Aoki T; Okubo H; Watanabe K; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
    J Gastroenterol Hepatol; 2015 Feb; 30(2):292-8. PubMed ID: 25339607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs.
    Hawkey CJ
    Gut; 2000 Mar; 46(3):310-1. PubMed ID: 10673289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer.
    Henriksson AE; Edman AC; Nilsson I; Bergqvist D; Wadström T
    Scand J Gastroenterol; 1998 Oct; 33(10):1030-3. PubMed ID: 9829355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection.
    Ramsoekh D; van Leerdam ME; Rauws EA; Tytgat GN
    Clin Gastroenterol Hepatol; 2005 Sep; 3(9):859-64. PubMed ID: 16234022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study.
    Okan A; Tankurt E; Aslan BU; Akpinar H; Simsek I; Gonen O
    J Gastroenterol Hepatol; 2003 Jan; 18(1):18-25. PubMed ID: 12519219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
    Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients.
    McColl KE; el-Nujumi A; Murray L; el-Omar E; Gillen D; Dickson A; Kelman A; Hilditch TE
    Gut; 1997 Mar; 40(3):302-6. PubMed ID: 9135516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.